181 related articles for article (PubMed ID: 20800895)
1. Complement regulates TLR4-mediated inflammatory responses during intestinal ischemia reperfusion.
Pope MR; Hoffman SM; Tomlinson S; Fleming SD
Mol Immunol; 2010; 48(1-3):356-64. PubMed ID: 20800895
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of toll-like receptor 4 alleviates intestinal ischemia reperfusion injury and acute lung injury in mice.
Zhu Q; He G; Wang J; Wang Y; Chen W; Guo T
Oncotarget; 2017 Feb; 8(8):13678-13689. PubMed ID: 28099145
[TBL] [Abstract][Full Text] [Related]
3. TLR4-mediated Cox-2 expression increases intestinal ischemia/reperfusion-induced damage.
Moses T; Wagner L; Fleming SD
J Leukoc Biol; 2009 Oct; 86(4):971-80. PubMed ID: 19564573
[TBL] [Abstract][Full Text] [Related]
4. Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection.
Atkinson C; Song H; Lu B; Qiao F; Burns TA; Holers VM; Tsokos GC; Tomlinson S
J Clin Invest; 2005 Sep; 115(9):2444-53. PubMed ID: 16127466
[TBL] [Abstract][Full Text] [Related]
5. Targeted Complement Inhibition Protects Vascularized Composite Allografts From Acute Graft Injury and Prolongs Graft Survival When Combined With Subtherapeutic Cyclosporine A Therapy.
Zhu P; Bailey SR; Lei B; Paulos CM; Atkinson C; Tomlinson S
Transplantation; 2017 Apr; 101(4):e75-e85. PubMed ID: 28045880
[TBL] [Abstract][Full Text] [Related]
6. CR2+ marginal zone B cell production of pathogenic natural antibodies is C3 independent.
Woods KM; Pope MR; Hoffman SM; Fleming SD
J Immunol; 2011 Feb; 186(3):1755-62. PubMed ID: 21187447
[TBL] [Abstract][Full Text] [Related]
7. TLR2 modulates antibodies required for intestinal ischemia/reperfusion-induced damage and inflammation.
Pope MR; Fleming SD
J Immunol; 2015 Feb; 194(3):1190-8. PubMed ID: 25539820
[TBL] [Abstract][Full Text] [Related]
8. A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury.
Huang Y; Qiao F; Atkinson C; Holers VM; Tomlinson S
J Immunol; 2008 Dec; 181(11):8068-76. PubMed ID: 19017999
[TBL] [Abstract][Full Text] [Related]
9. The effect of C1 inhibitor on intestinal ischemia and reperfusion injury.
Lu F; Chauhan AK; Fernandes SM; Walsh MT; Wagner DD; Davis AE
Am J Physiol Gastrointest Liver Physiol; 2008 Nov; 295(5):G1042-9. PubMed ID: 18787060
[TBL] [Abstract][Full Text] [Related]
10. TLR4 mediates lung injury and inflammation in intestinal ischemia-reperfusion.
Ben DF; Yu XY; Ji GY; Zheng DY; Lv KY; Ma B; Xia ZF
J Surg Res; 2012 May; 174(2):326-33. PubMed ID: 21392794
[TBL] [Abstract][Full Text] [Related]
11. Depletion of gut commensal bacteria attenuates intestinal ischemia/reperfusion injury.
Yoshiya K; Lapchak PH; Thai TH; Kannan L; Rani P; Dalle Lucca JJ; Tsokos GC
Am J Physiol Gastrointest Liver Physiol; 2011 Dec; 301(6):G1020-30. PubMed ID: 21903760
[TBL] [Abstract][Full Text] [Related]
12. A complement C3 inhibitor specifically targeted to sites of complement activation effectively ameliorates collagen-induced arthritis in DBA/1J mice.
Song H; Qiao F; Atkinson C; Holers VM; Tomlinson S
J Immunol; 2007 Dec; 179(11):7860-7. PubMed ID: 18025232
[TBL] [Abstract][Full Text] [Related]
13. Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire.
Fleming SD; Shea-Donohue T; Guthridge JM; Kulik L; Waldschmidt TJ; Gipson MG; Tsokos GC; Holers VM
J Immunol; 2002 Aug; 169(4):2126-33. PubMed ID: 12165541
[TBL] [Abstract][Full Text] [Related]
14. Intracellular Activation of Complement 3 Is Responsible for Intestinal Tissue Damage during Mesenteric Ischemia.
Satyam A; Kannan L; Matsumoto N; Geha M; Lapchak PH; Bosse R; Shi GP; Dalle Lucca JJ; Tsokos MG; Tsokos GC
J Immunol; 2017 Jan; 198(2):788-797. PubMed ID: 27913632
[TBL] [Abstract][Full Text] [Related]
15. TLR ligand decreases mesenteric ischemia and reperfusion injury-induced gut damage through TNF-alpha signaling.
Chen LW; Chang WJ; Chen PH; Liu WC; Hsu CM
Shock; 2008 Nov; 30(5):563-70. PubMed ID: 18317407
[TBL] [Abstract][Full Text] [Related]
16. Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells.
Tsung A; Hoffman RA; Izuishi K; Critchlow ND; Nakao A; Chan MH; Lotze MT; Geller DA; Billiar TR
J Immunol; 2005 Dec; 175(11):7661-8. PubMed ID: 16301676
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter infection alters MyD88 and Trif signalling in response to intestinal ischaemia-reperfusion.
Hoffman SM; Wang H; Pope MR; Fleming SD
Exp Physiol; 2011 Feb; 96(2):104-13. PubMed ID: 21056969
[TBL] [Abstract][Full Text] [Related]
18. Complement inhibitor, complement receptor 1-related gene/protein y-Ig attenuates intestinal damage after the onset of mesenteric ischemia/reperfusion injury in mice.
Rehrig S; Fleming SD; Anderson J; Guthridge JM; Rakstang J; McQueen CE; Holers VM; Tsokos GC; Shea-Donohue T
J Immunol; 2001 Nov; 167(10):5921-7. PubMed ID: 11698469
[TBL] [Abstract][Full Text] [Related]
19. Ischemic Preconditioning-Induced SOCS-1 Protects Rat Intestinal Ischemia Reperfusion Injury via Degradation of TRAF6.
Liu SZ; He XM; Zhang X; Zeng FC; Wang F; Zhou XY
Dig Dis Sci; 2017 Jan; 62(1):105-114. PubMed ID: 27538408
[TBL] [Abstract][Full Text] [Related]
20. Intestinal lipid alterations occur prior to antibody-induced prostaglandin E2 production in a mouse model of ischemia/reperfusion.
Sparkes BL; Slone EE; Roth M; Welti R; Fleming SD
Biochim Biophys Acta; 2010 Apr; 1801(4):517-25. PubMed ID: 20083230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
